What's breaking now, across thousands of outlets.
NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.
We haven't written up this one. The Sydney Morning Herald has the full story — the link below goes straight to it.
The 65-year-old reportedly attended City International Hospital in Ho Chi Minh and was moved to intensive care at another hospital after developing complications.
The 65-year-old reportedly attended City International Hospital in Ho Chi Minh and was moved to intensive care at another hospital after developing complications.
[Namibian] Why did it not act sooner?
The Pakistan Medical and Dental Council (PMDC) has introduced new titles for doctors undergoing postgraduate medical training across the country.
The person is believed to have taken the medication in the days after the death of their partner, who had been diagnosed with cancer, earlier this year.
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and appearing in The Lancet shows that treatment with…
